Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Neoplasms of the CNS

  Free Subscription


01.12.2025

1 Acta Neuropathol
4 AJNR Am J Neuroradiol
5 BMC Cancer
1 Brain
5 Childs Nerv Syst
7 J Neurooncol
1 Neuro Oncol
1 Neuroradiology
2 Neurosurgery
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. FURST A, Ruf V, Fiedler C, Rutkowski S, et al
    IDH mutations are rare events in SHH medulloblastoma.
    Acta Neuropathol. 2025;150:55.
    PubMed        


    AJNR Am J Neuroradiol

  2. YANG H, Zhu Z, Zhou L, Zhou J, et al
    Clinical and VASARI Features to Predict CDKN2A/B Homozygous Deletion in IDH-Mutant Astrocytomas: A Multicenter Study.
    AJNR Am J Neuroradiol. 2025;46:2107-2115.
    PubMed         Abstract available

  3. MASHRIQI F, Chen M, Keir G, Caravella C, et al
    Hybrid [(18)F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET Imaging.
    AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8863.
    PubMed         Abstract available

  4. UCISIK FE, Khanpara S, Ozkara BB, Li Z, et al
    Adoption of the T2-FLAIR Mismatch Sign among Radiologists: How Well Are We Doing?
    AJNR Am J Neuroradiol. 2025;46:2091-2097.
    PubMed         Abstract available

  5. PEI H, Lyu Y, Lambrecht S, Lin D, et al
    Deep Learning-Based Generation of DSC MRI Parameter Maps Using Dynamic Contrast-Enhanced MRI Data.
    AJNR Am J Neuroradiol. 2025;46:2075-2083.
    PubMed         Abstract available


    BMC Cancer

  6. HAN R, Chi G, Sun D, Xu Z, et al
    Single-cell and spatial transcriptomics reveal lactylation-associated tumor cell clusters and define a prognostic risk model in glioblastoma.
    BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15291.
    PubMed         Abstract available

  7. YING L, Yangmei S, Qing X, Yuyu D, et al
    Construction and validation of a risk prediction model for symptom cluster distress in brain tumor patients: a cross-sectional study.
    BMC Cancer. 2025;25:1803.
    PubMed         Abstract available

  8. LYU Q, Yuan H, Lin Z, Barcus R, et al
    A large scale multi-dataset investigation of brain metastases distribution based on primary cancer type.
    BMC Cancer. 2025;25:1821.
    PubMed         Abstract available

  9. WEI J, Zou L, Liu Q, Xie Y, et al
    Identifying NDUFB2 as a prognostic biomarker for glioblastoma through an exploratory analysis of an anesthesia-related gene signature.
    BMC Cancer. 2025 Nov 27. doi: 10.1186/s12885-025-15312.
    PubMed        

  10. HASELMANN J, Roohani S, Wasilewski D, Onken J, et al
    The interdisciplinary management of craniopharyngioma - practice patterns, outcomes, and insights.
    BMC Cancer. 2025 Nov 28. doi: 10.1186/s12885-025-14991.
    PubMed         Abstract available


    Brain

  11. SOUMBASIS A, Ueno A, Elliott D, Lama S, et al
    The glymphatic system and glioblastoma.
    Brain. 2025 Nov 28:awaf449. doi: 10.1093.
    PubMed         Abstract available


    Childs Nerv Syst

  12. TAN XY, Teh DJW, Tan TSE
    Amelanotic melanoma of the central nervous system with systemic spread - imaging pitfalls and clues in a rare paediatric case with congenital melanocytic naevi.
    Childs Nerv Syst. 2025;41:386.
    PubMed         Abstract available

  13. ALI AJ, Li Q
    Rapid progression of a posterior fossa arachnoid cyst in a child following minor head trauma: a case report.
    Childs Nerv Syst. 2025;41:379.
    PubMed         Abstract available

  14. ZUO P, Jiang K, Zou W, Li H, et al
    Angiocentric glioma: a single center experience and literature review.
    Childs Nerv Syst. 2025;41:380.
    PubMed         Abstract available

  15. ESHWARAPPA VS, Saravanan PD, Pattar RG, D PS, et al
    A silent intruder: arachnoid cyst of the third ventricle of the brain- case report and review of literature.
    Childs Nerv Syst. 2025;41:373.
    PubMed         Abstract available

  16. KUBOTA H, Fukuoka K, Arakawa Y, Uchihara Y, et al
    Clinical challenges of cancer predisposition syndromes with pediatric central nervous system tumors: a single-center study.
    Childs Nerv Syst. 2025;41:370.
    PubMed         Abstract available


    J Neurooncol

  17. MASTRONUZZI A, Franceschi E, D'Antonio F, Bennicelli E, et al
    Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.
    J Neurooncol. 2025;176:95.
    PubMed         Abstract available

  18. BASARAN AE, Fahsold L, Lordick F, Nicolay NH, et al
    Treatment modalities in recurrent brain metastases: a combined institutional and individual patient data meta-analysis of post-recurrence survival and local progression-free survival.
    J Neurooncol. 2025;176:96.
    PubMed         Abstract available

  19. PAHWA B, Pahwa N, Sheehan JP
    Single session versus hypofractionated stereotactic radiosurgery for large meningiomas (> 8 cc): a systematic review and meta analysis.
    J Neurooncol. 2025;176:97.
    PubMed         Abstract available

  20. DARKO K, Chen J, Eckel-Passow JE, Fonkem E, et al
    Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival.
    J Neurooncol. 2025;176:98.
    PubMed        

  21. VARGAS LO, Himic V, Otaner F, Abikenari M, et al
    Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications.
    J Neurooncol. 2025;176:99.
    PubMed         Abstract available

  22. YOO J, Jung IH, Chang WS, Jung HH, et al
    Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding.
    J Neurooncol. 2025;176:100.
    PubMed        

  23. ROLDAN URGOITI G, de Robles P, Tsang RY, Willson M, et al
    A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.
    J Neurooncol. 2025;176:101.
    PubMed        


    Neuro Oncol

  24. ZHOU W, Martinez-Garcia E, Sarnow K, Kanli G, et al
    Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy.
    Neuro Oncol. 2025 Nov 24:noaf271. doi: 10.1093.
    PubMed         Abstract available


    Neuroradiology

  25. GREY A, Justus T, Wahl H, Engellandt K, et al
    Incidence and time course of new contrast-enhancing lesions on MRI after proton versus photon radiotherapy in glioma patients.
    Neuroradiology. 2025 Nov 24. doi: 10.1007/s00234-025-03829.
    PubMed         Abstract available


    Neurosurgery

  26. MAI Y, Jia H, Zhou H, Jiang K, et al
    Emotional-Behavioral Dysregulation and Cortical Alterations in Pediatric Diffuse Midline Glioma With H3K27M Mutant: A Case-Control Study.
    Neurosurgery. 2025 Nov 25. doi: 10.1227/neu.0000000000003860.
    PubMed         Abstract available

  27. CHEN KT, Tsai HC, Huang CY, Liau CT, et al
    Combination of Neuronavigation-Guided Focused Ultrasound and Bevacizumab for Patients With Recurrent Glioblastoma: A Pilot Study.
    Neurosurgery. 2025 Nov 24. doi: 10.1227/neu.0000000000003851.
    PubMed         Abstract available


    PLoS One

  28. ZENG J, Lin L, Ma Y, Huang W, et al
    Single-cell transcriptomics profiling reveals cellular origins and molecular drivers underlying melanoma brain metastasis.
    PLoS One. 2025;20:e0336502.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.